Legence (LGN) EBITDA (2024 - 2026)

Legence has reported EBITDA for 3 years, with the latest figure at -$6.6 million in Q2 2026.

• On a quarterly basis, EBITDA fell 121.12% year-over-year to -$6.6 million in Q2 2026; TTM through Jun 2026 was $38.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $93.5 million, down 6.75% from the prior year.
• EBITDA was -$6.6 million for Q2 2026 at Legence, up from -$23.5 million in the prior quarter.
• The five-year high for EBITDA was $37.2 million in Q3 2025, with the low at -$23.5 million in Q4 2025.
• Average EBITDA over 3 years is $11.8 million, with a median of $16.3 million recorded in 2024.
• The largest YoY upside for EBITDA was 38.02% in 2025 against a maximum downside of 521.64% in 2025.
• Over 3 years, EBITDA stood at $5.6 million in 2024, then plunged by 521.64% to -$23.5 million in 2025, then soared by 71.84% to -$6.6 million in 2026.
• The last three EBITDA figures came in at -$6.6 million (Q2 2026), -$23.5 million (Q4 2025), and $37.2 million (Q3 2025), per Business Quant data.